Objective-Extracellular matrix (ECM) of neointima formed following angioplasty contains elevated levels of versican, loosely arranged collagen, and fragmented deposits of elastin, features associated with lipid and macrophage accumulation. ECM with a low versican content, compact structure, and increased elastic fiber content can be achieved by expression of versican variant V3, which lacks chondroitin sulfate glycosaminoglycans. We hypothesized that V3-expressing arterial smooth muscle cells (ASMC) can be used to form a neointima resistant to lipid and macrophage accumulation associated with hypercholesterolemia. Methods and Results-ASMC transduced with V3 cDNA were seeded into ballooned rabbit carotid arteries, and animals were fed a chow diet for 4 weeks, followed by a cholesterol-enriched diet for 4 weeks, achieving plasma cholesterol levels of 20 to 25 mmol/L. V3 neointimae at 8 weeks were compact, multilayered, and elastin enriched. They were significantly thinner (57%) than control neointimae; contained significantly more elastin (118%), less collagen (22%), and less lipid (76%); and showed significantly reduced macrophage infiltration (85%). Mechanistic studies demonstrated that oxidized low-density lipoprotein stimulated the formation of a monocyte-binding ECM, which was inhibited in the presence of V3 expressing ASMC. Conclusion-These results demonstrate that expression of V3 in vessel wall creates an elastin-rich neointimal matrix that in the presence of hyperlipidemia is resistant to lipid deposition and macrophage accumulation. (Arterioscler Thromb Vasc Biol. 2011;31:1309-1316.)
N eointima that develops following angioplasty is characterized by extracellular matrix (ECM) containing elevated levels of the chondroitin sulfate proteoglycan (CSPG) versican, loosely arranged collagen, and scattered deposits of elastin, features that predispose to lipid and macrophage accumulation. 1, 2 In both humans and animal models of atherosclerosis, versican is a prominent ECM component that accumulates in the arterial intima and plays important roles in atherogenesis, including trapping of low-density lipoproteins and promotion of inflammation. 3 The chondroitin sulfate (CS)-rich glycosaminoglycan chains of versican, which are present in the 3 principal variants (V0, V1, and V2), are integral to these roles. For example, the negatively charged CS glycosaminoglycans bind cationic-rich sequences of apolipoprotein B-100 of low-density lipoprotein 4 which leads to monocyte ingress, differentiation to macrophages, uptake of lipid-proteoglycan (PG) complexes, and formation of foam cells. 5, 6 Recent evidence indicates that versican also plays a direct role in the inflammatory response. V1 stimulates expression of the proinflammatory cytokines tumor necrosis factor-␣ and interleukin-6 by macrophages through Toll-like receptor family members. 7 In addition, in the Athsq1 mouse model of atherosclerosis, which exhibits large macrophage-rich lesions, versican accumulation is mediated by macrophages. 8 Versican also mediates leukocyte aggregation through binding to P-selectin glycoprotein ligand-1, 9 and more recently it has been demonstrated that versican plays a critical role in hyaluronan-dependent binding of monocytes to ECM. 10, 11 Accumulation of versican in the cardiovascular system, such as in neointimae formed following angioplasty 12 and CS accumulation in patients with the genetic diseases Costello syndrome and Hurler disease, 13 is associated with impaired elastogenesis and aberrant remodeling of arterial walls. Chondroitin sulfate glycosaminoglycans interfere with the assem-bly of tropoelastin into elastic fibers. 14, 15 Notably, however, the versican variant V3, which lacks CS, does not interfere with elastic fiber assembly; rather, when overexpressed, it markedly enhances tropoelastin expression and its assembly into elastic fibers, both in vitro 13, 16 and in vivo. 16 Collectively, these data predict that expression of V3 by arterial smooth muscle cells (ASMC) could potentially have several beneficial effects on vessel wall, such as increased elastin content, reduced accumulation of atherogenic lipids, and, importantly, a reduced macrophage-mediated inflammatory response. We provide evidence in support of this hypothesis, using an established angioplasty model and a hypercholesterolemic stimulus, and demonstrate that expression of V3 provides a novel approach for inhibiting atherogenic changes.
Methods
A full description of methods can be found in the Supplemental Material (available online at http://atvb.ahajournals.org).
Cell Culture
Primary ASMC were obtained from rabbit aortae by explant outgrowth and cultured as previously described. 17 Cells were used between passages 3 and 10.
Retroviral Transduction and In Vitro Analyses
Full-length sense rat V3 cDNA was inserted into the BamHI site of the empty retroviral vector (LXSN) (courtesy of D.A. Miller, Fred Hutchinson Cancer Research Center, Seattle, WA) to produce the V3-containing vector (LV3SN) using methodology described previously. 18 Transduction was confirmed by in situ hybridization 19 using a tagged DNA primer, Texas Red-X-TCC CGC TTC AGT GAC AAC GTC GAG CAC AGC (Invitrogen), to detect mRNA for the selectable marker neomycin phosphotransferase II. Induction of the elastogenic phenotype in V3-transduced ASMC was confirmed by immunostaining for elastin and by analysis of insoluble elastin, measured as previously described 13 (see Supplemental Figure I ).
Balloon Catheter Injury and Cell Seeding
Balloon injury and cell seeding experiments were approved by the University of Auckland Animal Ethics Committee (approval R435). Right common carotid arteries of young adult male New Zealand White rabbits (average weight, 2.3 kg) were deendothelialized using the method of Manderson et al. 20 Following isolation of the right common carotid, transduced cells (empty vector and V3, 60ϫ10 3 per 0.1 mL of serum-free growth medium) were introduced via a syringe and flexible catheter and allowed to dwell for 15 minutes. Flow was reestablished, and the wound closed. Approved anesthetic agents and postoperative pain control measures were used (see Supplemental Methods). Animals were euthanized at 8 weeks, and vessels were perfusion-fixed in 2.5% paraformaldehyde under pressure. Nine rabbits were seeded with control-transduced ASMC and 9 with V3-transduced ASMC. Initial histological analysis showed that 3 control-and 2 V3-seeded vessels were occluded, with degenerate media indicating early occlusion; these vessels were excluded from subsequent analyses. The presence of seeded ASMC in neointimae was confirmed by in situ hybridization using the Texas Red-tagged DNA probe. Consistent with previous studies, 21 transduced cells were present in control and V3 neointimae, dispersed among host cells, and restricted to neointimae (see Supplemental Figure II ).
Experimental Protocol and Cholesterol Feeding
All animals were fed a normal chow diet for 4 weeks to allow them to develop a neointima in the absence of cholesterol feeding. At the beginning of week 5, the normal chow was replaced with cholesterol-coated pellets, 0.15% by weight, 22 increased to 0.3% by weight at the beginning of week 7. Blood samples were taken in weeks 4, 5, 7, and at the end of week 8 for total cholesterol analysis by LabPLUS, Auckland Hospital, Auckland, New Zealand.
Histochemistry
Ten-micrometer frozen tissue sections, cut from O.C.T.-mounted fixed vessel segments, were stained with Oil Red O for lipid and neutral triglycerides and with orcein for elastin. Oil Red O provided the necessary depth of color and definition 23 for morphometric analysis. Thin (1 m) sections cut from epon-embedded vessel segments were stained in 1% toluidine blue.
Immunodetection of CSPG and Macrophages
CSPG and macrophages were detected in paraformaldehyde-fixed sections using mouse monoclonal antibody 9BA12 (Developmental Studies Hybridoma Bank, University of Iowa) and mouse anti-rabbit RAM11 24 (Dako) respectively. RAM11 recognizes all tissue macrophages in rabbits, particularly those residing in vascular wall in animals on both normal and hypercholesterolemic (Western) diets 23 and does not cross-react with human, rat or monkey macrophages. 25
Morphometric Analyses
Vessel parameters and lipid and macrophage content were determined by morphometric analysis of multiple images using the public domain NIH Image program (http://rsb.info.nih.gov/nih-image/).
Electron Microscopy
Structure and organization of neointimae were assessed by electron microscopy. Morphometric analysis of multiple images was used to determine changes in content and distribution of constituent extracellular components of elastin, collagen, and matrix, as previously described 26, 27 (see Supplemental Figure III ).
Monocyte Adherence Assays
Adherence of human monocytes (U937) to ECM produced by control and V3-transduced ASMC in the absence and presence of tunicamycin and oxidized low-density lipoprotein (oxLDL), and to collagen and elastin gels, was measured using established assays. 10, 28 Human oxLDL was prepared as previously described. 29 
Statistics
Data were analyzed by 2-tailed Student t test and, where indicated, by paired t test. A value of PϽ0.05 was taken as significant. Data are presented as meanϮSEM.
Results

Plasma Cholesterol Levels
Following balloon angioplasty and cell seeding, all animals were placed on a regular chow diet for 4 weeks. Mean total plasma cholesterol level for all animals in week 4 was 1.8 mmol/L, with no difference between vector-alone and V3 animals ( Figure 1 ). All animals were placed on a 0.15% cholesterol diet for weeks 5 and 6 and a 0.3% cholesterol diet for weeks 7 and 8. Final cholesterol levels were 20 to 25 mmol/L, with no significant difference between groups (Figure 1 ).
Neointimal Structure and Composition
Neointimae of carotids seeded with V3-expressing ASMC were significantly thinner than carotids seeded with vector-alone ASMC (57%) (PϽ0.03) ( Figure 2A ). Medial widths were not significantly different, and neointimal-medial width ratios reflected the thinner neointimae of the V3 animals (data not shown). The ECM of control neointimae showed a typical myxoid structure, characteristic of neointimae that develop following ballooning, of loosely arranged collagen bundles and scattered deposits of elastin, usually more prominent in the mid to deep musculoelastic layer than the subendothelial zone ( Figures 2B and 3A) . In contrast, the ECM of V3 neointimae was significantly more compact with a layered structure, reflected by circumferentially arranged multiple bands of elastin between elongated ASMC ( Figures 2C and 3D ). These bands of elastin were strongly autofluorescent ( Figure 2E ), indicative of cross-links and maturation 30 and were especially prominent in the subendothelial zone. On the other hand, the scattered small elastin deposits in the neointimae of the controls showed minimal autofluorescence and only in the mid to deep neointimal layers ( Figure 2D ; yellow fluorescence in Figure 2D is lipid 31 ). To evaluate CSPG content, sections were stained with 9BA12, which specifically recognizes CS. Control neointimae stained strongly with 9BA12, notably in the lipid and macrophage-rich areas ( Figure 2F ). In contrast, compact V3 neointimae stained lightly or not at all for CS ( Figure 2G ).
Electron microscopy of control neointima revealed small scattered deposits of elastin and small-diameter, randomly oriented collagen fibrils in the subendothelial zone ( Figure  3B ) and more prominent but discrete deposits of elastin in an open matrix containing bundles of woven collagen fibrils in the midintimal ( Figure 3C ) and deeper regions. On the other hand, neointimae of V3-seeded vessels contained prominent, multiple, circumferentially arranged bands of elastin throughout the full width of neointimae in a matrix with reduced collagen and between elongated, differentiated ASMC ( Figure 3E and 3F). The bands of elastin between adjacent ASMC were frequently bilamina ( Figure 3F and 3G), indicative of a dual origin from opposing parallel ASMC, a feature reported previously for formation of medial elastic lamellae. 32 Morphometric analysis of electron micrographs confirmed that the ECM compartment of V3 neointimae contained a significantly increased content of elastin (118%, PϽ0.01) and small but significant reductions of collagen (22%, PϽ0.05) and matrix space (20%, PϽ0.02) compared with control neointima ( Figure 3I ). Analysis of the neointimal subregions showed further differences in the content of elastin ( Figure 3J ). In vector control neointimae, elastin content was higher in the mid and deeper zones compared with the subendothelial zone. In con-trast, the elastin content of V3 neointimae was higher overall and similar across all zones of the neointimae, with the subendothelial region showing the largest increase in elastin (196% increase, PϽ0.02) ( Figure 3J ). Analysis of total neointimae showed that cell and ECM volumes fractions were not significantly different between the 2 groups, although there was a trend toward reduced ECM in the V3 neointimae ( Figure 3H) , indicating that the increase in elastin largely compensated for the decrease in collagen and matrix space.
Lipid Accumulation
Lipid accumulation was assessed by morphometric analysis of Oil Red O-stained sections. V3 neointimae had a significantly reduced total lipid content (80% reduction, PϽ0.03) and a reduced lipid content expressed as a percentage of Figure 4A and 4B ). Thickened vector control neointimae often contained extensive deposits of lipid ( Figure 4C and 4D ). Some control neointimae were minimally thickened but also positive for lipid (Supplemental Figure IVC) . Overall, lipid occupied 20% of neointimal area of control vessels. In contrast, lipid occupied 5% of neointimal area of V3-seeded vessels, with the thin neointimae frequently completely devoid of lipid ( Figure 4E and 4F) . Lipid deposits, where present, were generally more diffuse and often restricted to small focal lesions and with the 
Macrophage Accumulation
Macrophage accumulation was assessed by morphometric analysis of RAM11 immunostaining. Control neointimae stained strongly for RAM11-positive macrophages, which were largely distributed and colocated to the lipid-positive regions, and notably in the subendothelial zone ( Figure 5A to 5C). Macrophages were also present in the deep neointima and less frequently in the inner media ( Figure 5C ). Lipidnegative V3 neointimae did not stain for macrophages (Fig- ure 5D to 5F). In some V3 vessels or vessel segments, small, discrete, raised subendothelial lesions contained accumulation of macrophages ( Figure 5G and 5H) . Rarely were macrophages seen in the media. (For additional images, see Supplemental Figure V .) Morphometric analysis confirmed the reduced accumulation of macrophages in the neointimae and media of V3 compared with control animals (85% reduction, PϽ0.008) ( Figure 5I ).
In Vitro Mechanistic Studies
There are a number of different mechanisms that may explain the in vivo observations. First, we addressed whether exposure of ASMC to modified low-density lipoprotein in the form of oxLDL stimulates formation of an ECM that binds monocytes in a hyaluronan-dependent manner. Previous studies in our laboratory have shown that oxLDL alters production of PGs by ASMC. 29 Because hypercholesterolemia was the in vivo stimulus used in the current study, we asked whether lipids induce ASMC to produce an ECM that binds monocytes. We treated the ASMC with oxLDL, or, as a positive control, tunicamycin, which is known to promote the formation of an ECM by ASMC that binds monocytes in a hyaluronan-dependent manner, 33 and we found that oxLDL promoted formation of an ECM that bound monocytes in a hyaluronan-dependent manner ( Figure 6A ). V3-generated ECM, however, was significantly less adherent for human monocytes when stimulated with either oxLDL or tunicamycin (PϽ0.005) ( Figure 6A ).
To determine whether the elastin-rich ECM generated by V3-expressing ASMC resists monocyte adhesion, we compared the ability of collagen versus elastin to support monocyte adhesion using an in vitro assay. Artificial matrices containing elastin were significantly less adherent for monocytes compared with gels containing collagen (PϽ0.01; Figure 6B ). These data, coupled to our in vivo observations in this current study, support a protective role for elastic fibers as antiinflammatory elements in the ECM.
Discussion
Transduction and seeding of ASMC expressing versican variant V3 into ballooned rabbit carotid arteries resulted in formation of highly structured and elastin-rich neointimae resistant to lipid deposition and to macrophage ingress. Our previous investigations in the rat similarly demonstrated that V3-expressing ASMC form structurally compact neointimae with multiple layers of elastin. 16 This present study demonstrates that such neointimae have the significant additional advantage of resistance to lipid deposition and to inflammatory changes stimulated by hypercholesterolemia. Our finding that oxLDL promotes formation of a matrix that binds monocytes in a hyaluronan-dependent manner is of particular interest. Previous studies have shown that agents that promote endoplasmic reticulum stress in ASMC, such as tunicamycin and poly(IC), stimulate the formation of a hyaluronan-dependent proadhesive ECM for monocytes. 33, 34 It is clear that oxLDL is capable of promoting endoplasmic reticulum stress in vascular cells, 35 but whether this pathway is responsible for the ECM inductive effect of oxLDL in the present study is not yet certain. What is remarkable, however, is that V3 expressed by ASMC reduces the capacity of monocytes to bind to the ECM induced by classical stimulators of endoplasmic reticulum stress, such as tunicamycin and proatherogenic oxLDL. Such findings highlight a potential therapeutic application for V3.
The inverse relationship between elastin distribution and regions of lipid deposition and inflammatory changes has been recognized previously and is reflected in the classification of human lesions. 36 In the early stages of lesion development, intimal thickenings have 2 distinct zones, a subendothelial PG-rich zone, depleted in elastin and where lipid is first deposited and where monocytes first ingress, and a deeper lipid-free musculoelastic or musculofibrous zone 37 where the elastin and collagen content is higher and PG content lower. These regional structural differences are present also in neointima induced by balloon catheter injury, including the rabbit 20, 38 in which synthetic ASMC in the subendothelial zone synthesize and secrete higher amounts of matrix PGs than differentiated contractile ASMC 39 in the musculoelastic layer.
In addition to increased elastin content, V3 neointimae in this study were also characterized by a reduced content of CS. Other studies have reported that V3 expression leads to reduced CSPG, including decreased accumulation of aggrecan by chondrocytes. 40 The importance of CSPGs for trapping of lipoproteins has been demonstrated experimentally, 5 and it has been shown that susceptibility of coronary bypass vessels to atherosclerosis relates to CSPG content. 41 The enhanced formation of elastic fibers in V3 neointimae is likely directly related to reduced versican. The precise signaling mechanism by which V3 overexpression induces formation of elastic fibers is not yet clear. Elastic fibers are assembled at cell surfaces and versican, as well as free CS chains, prevent fiber assembly by causing premature shedding of the elastin binding receptor (spliced variant of ␤-galactosidase) from the cell surface, preventing transfer of tropoelastin to the microfibrillar scaffold. [13] [14] [15] Notably, V3expressing cells are characterized by reduced pericellular matrix, 18 known to be enriched in versican. 42 We postulate that reduction in cell surface versican permits a longer residence time for elastin binding receptor and enhanced assembly of elastin into fibers. 3 Reduction of versican at the cell surface by overexpression of versican antisense similarly enhances elastogenesis in neointima. 43 Notably, subendothelial ASMC of normal neointima actively synthesize and secrete tropoelastin, 44 but assembly into elastic fibers does not take place in this region of high versican content. 12 Versican also forms hydrated matrices that favor cell proliferation. 42 Moreover, a reciprocal relationship between heightened cellular proliferation and lack of mature elastic fiber deposition has been documented in cultures of ASMC and fibroblasts derived from patients with supravalvular aortic stenosis. This relationship has also been noted in Williams-Beuren syndrome, where there is haploinsuficiency of the elastin gene, 45 and in elastin Ϫ/Ϫ transgenic mice. 46 Thus, reducing CS and maintaining existing elastic fibers, as well as stimulating formation of new fibers in a CS-depleted environment, may be an effective strategy for preventing cell proliferation and restenosis associated with angioplasty. Our finding of reduced levels of immunodetectable CS and the absence of lipid in the neointimae of the V3 hypercholesterolemic rabbits suggests that V3-mediated reduction of CS in the vessel wall may constitute an effective strategy for preventing development of atherosclerotic lesions.
This study demonstrates that expression of V3 produces a stable vessel wall that exhibits antiinflammatory properties. Our finding of reduced monocyte adherence to matrix generated by V3 ASMC, and to elastin-containing gels compared with collagen gels, indicates a possible mechanism that explains these antiinflammatory properties. In vessel wall, intact elastic fibers are considered to reduce ongoing invasion of monocytes that normally respond chemotactically to elastin degradation products resulting from elastolysis by macrophage-derived matrix metalloproteinases. 47 Decellularized arterial elastic lamellae prevent monocyte adhesion and transmigration by activating signal regulatory protein ␣ and Src homology 2 domain containing protein-tyrosine phosphatase-1 in monocytes. 48 Furthermore, ASMC phenotype is affected by the mechanical properties and rigidity of the ECM, which effects cell adhesion, migration, and proliferation. 49 -51 Lipid content, however, may also affect inflammatory changes. Observations on early human atherosclerosis show that lipid accumulation consistently precedes macrophage ingress, 52 and the reduced ingress of macrophage in the V3 animals is consistent with this model of matrix-driven lipid influence on macrophage ingress and accumulation. Notably, in our in vitro assay, monocyte adherence to matrix was significantly reduced in V3 cell cultures stimulated by oxLDL, indicating that V3 matrix has antiinflammatory properties under hypercholesterolemic conditions.
The structural changes seen in V3 neointima, particularly as revealed by electron microscopy, demonstrate a major and significant change in the balance and organization of ECM components, to an extent not previously reported. The formation of multiple layers of elastin throughout the full width of V3 neointimae, including the subendothelial zone, where lipid deposition and inflammatory changes normally first occur, demonstrates that overexpression of V3 effects a major structural reorganization. Although a number of mechanisms may be responsible for the V3 effects, the capacity for V3 to enrich the ECM with elastin and to stimulate a matrix with a reduced CSPG content and reduced adherence for monocytes are beneficial effects that can be used to engineer a neointima resistant to early lipid deposition and macrophage infiltration. We note also that the ability of V3 to confer improved structural characteristics and stability to vessels could have wider application for the repair of damaged and aneurysmal vessels or aortic dissection.
